Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
Please provide your email address to receive an email when new articles are posted on . Oral testosterone undecanoate is an effective long-term therapy for men with hypogonadism, with a safety profile ...
RALEIGH, N.C., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that KYZATREX ® (testosterone undecanoate) CIII capsules will be highlighted in three research abstracts ...
AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men To view the multimedia ...
NORTHBROOK, Ill., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by ...
Jatenzo (testosterone undecanoate) is a prescription drug that’s used to treat low testosterone levels. The drug comes as a capsule that you swallow. It’s usually taken twice per day. Jatenzo is ...
HYATTSVILLE, Md. -- An FDA advisory committee voted 13-6 today against recommending the approval of the oral testosterone undecanoate capsule Tlando (Lipocine) for the treatment of hypogonadism in ...
NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
Long-term treatment with testosterone undecanoate was associated with reduced cardiovascular morbidity and mortality in patients with hypogonadism and type 2 diabetes. SAN FRANCISCO — Long-term ...
- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years- JATENZO is an oral softgel testosterone undecanoate for testosterone ...
AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men DUBLIN, March 6, 2014 ...